CD40 and neoplasm: Priming T-cell responses requires sufficient antigen presentation by APCs; therefore, patients were treated with gemcitabine with CD40 agonist delivered several days after the first dose of gemcitabine.127 This approach was used with the hypothesis that chemotherapy would elicit some tumor cell killing to provide APCs in the lymphoid organs with antigen released from dying tumors.